FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2127289995> ?p ?o ?g. }

• W2127289995 endingPage "366" @default.
• W2127289995 startingPage "360" @default.
• W2127289995 abstract "Somatostatin is a peptide with a potent and broad antisecretory action, which makes it an invaluable drug target for the pharmacological management of pituitary adenomas and neuroendocrine tumors. Furthermore, somatostatin (SST) receptors (SSTR1, 2A and B, 3, 4 and 5) belong to the G protein coupled receptor family and are overexpressed in tumors. Since, human small-cell lung cancer overexpresses somatostatin receptors (STTR), they could be legitimate targets for treating SCLC.The aim of this study was the evaluation of cytotoxicity of somatostatin in combination with several anticancer drugs in HTB-175 cell line (Small Cell Lung Cancer Cell line that expresses neuron specific enolase).Docetaxel, Paclitaxel, Carboplatin, Cisplatin, Etoposide, Gemzar, Navelbine, Fluorouracil, Farmorubicin are the chemotherapeutic drugs that we used for the combination before and after adding somatostatin in SCLC cell culture. HTB-175 cell line was purchased from ATCC LGC Standards.At indicated time-point, 48h after the combination, cell viability and apoptosis were measured with Annexin V staining by flow cytometry.Flow cytometry showed that Docetaxel, Paclitaxel, Gemzar and Cisplatin induced apoptosis more when they were added before somatostatin, whereas etoposide induced apoptosis more after somatostatin treatment. Navelbine alone or in combination with somatostatin showed no differences in apoptosis. Farmorubicin showed equal toxicity in all combinations. Fluorouracil and Carboplatin induced apoptosis more when added alone in HTB-175 cell line. However, increased apoptosis was also observed when Carboplatin was administered before somatostatin in higher concentrations.Our results indicated that depending on the drug, somatostatin treatment before or after chemotherapeutic drugs increased apoptosis in small cell lung cancer cells. We suggest that long acting somatostatin analogues could be used as additive and maintenance therapy in combination to antineoplastic agents in SCLC patients." @default.
• W2127289995 created "2016-06-24" @default.
• W2127289995 creator A5015401016 @default.
• W2127289995 creator A5015640081 @default.
• W2127289995 creator A5017513274 @default.
• W2127289995 creator A5023794918 @default.
• W2127289995 creator A5025356528 @default.
• W2127289995 creator A5031354667 @default.
• W2127289995 creator A5033733633 @default.
• W2127289995 creator A5034276870 @default.
• W2127289995 creator A5034625178 @default.
• W2127289995 creator A5035067005 @default.
• W2127289995 creator A5037442955 @default.
• W2127289995 creator A5037835689 @default.
• W2127289995 creator A5063290792 @default.
• W2127289995 creator A5075548205 @default.
• W2127289995 creator A5077387864 @default.
• W2127289995 creator A5082059315 @default.
• W2127289995 creator A5086681842 @default.
• W2127289995 creator A5088505116 @default.
• W2127289995 creator A5088970861 @default.
• W2127289995 date "2015-01-01" @default.
• W2127289995 modified "2023-10-04" @default.
• W2127289995 title "Could Somatostatin Enhance the Outcomes of Chemotherapeutic Treatment in SCLC?" @default.
• W2127289995 cites W1965723936 @default.
• W2127289995 cites W1967417567 @default.
• W2127289995 cites W1982055976 @default.
• W2127289995 cites W1996372291 @default.
• W2127289995 cites W2005592237 @default.
• W2127289995 cites W2005993405 @default.
• W2127289995 cites W2006850701 @default.
• W2127289995 cites W2016356824 @default.
• W2127289995 cites W2039076228 @default.
• W2127289995 cites W2040127137 @default.
• W2127289995 cites W2041267935 @default.
• W2127289995 cites W2047581019 @default.
• W2127289995 cites W2056129241 @default.
• W2127289995 cites W2072451695 @default.
• W2127289995 cites W2076302815 @default.
• W2127289995 cites W2083764282 @default.
• W2127289995 cites W2085998656 @default.
• W2127289995 cites W2104702379 @default.
• W2127289995 cites W2105081091 @default.
• W2127289995 cites W2126412073 @default.
• W2127289995 cites W2147713995 @default.
• W2127289995 cites W2152755651 @default.
• W2127289995 cites W2155161822 @default.
• W2127289995 cites W2159877354 @default.
• W2127289995 cites W2162011212 @default.
• W2127289995 cites W2162724777 @default.
• W2127289995 cites W2168340462 @default.
• W2127289995 cites W2212041110 @default.
• W2127289995 doi "https://doi.org/10.7150/jca.11308" @default.
• W2127289995 hasPubMedCentralId "https://www.ncbi.nlm.nih.gov/pmc/articles/4349876" @default.
• W2127289995 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/25767606" @default.
• W2127289995 hasPublicationYear "2015" @default.
• W2127289995 type Work @default.
• W2127289995 sameAs 2127289995 @default.
• W2127289995 citedByCount "10" @default.
• W2127289995 countsByYear W21272899952016 @default.
• W2127289995 countsByYear W21272899952017 @default.
• W2127289995 countsByYear W21272899952018 @default.
• W2127289995 countsByYear W21272899952019 @default.
• W2127289995 countsByYear W21272899952023 @default.
• W2127289995 crossrefType "journal-article" @default.
• W2127289995 hasAuthorship W2127289995A5015401016 @default.
• W2127289995 hasAuthorship W2127289995A5015640081 @default.
• W2127289995 hasAuthorship W2127289995A5017513274 @default.
• W2127289995 hasAuthorship W2127289995A5023794918 @default.
• W2127289995 hasAuthorship W2127289995A5025356528 @default.
• W2127289995 hasAuthorship W2127289995A5031354667 @default.
• W2127289995 hasAuthorship W2127289995A5033733633 @default.
• W2127289995 hasAuthorship W2127289995A5034276870 @default.
• W2127289995 hasAuthorship W2127289995A5034625178 @default.
• W2127289995 hasAuthorship W2127289995A5035067005 @default.
• W2127289995 hasAuthorship W2127289995A5037442955 @default.
• W2127289995 hasAuthorship W2127289995A5037835689 @default.
• W2127289995 hasAuthorship W2127289995A5063290792 @default.
• W2127289995 hasAuthorship W2127289995A5075548205 @default.
• W2127289995 hasAuthorship W2127289995A5077387864 @default.
• W2127289995 hasAuthorship W2127289995A5082059315 @default.
• W2127289995 hasAuthorship W2127289995A5086681842 @default.
• W2127289995 hasAuthorship W2127289995A5088505116 @default.
• W2127289995 hasAuthorship W2127289995A5088970861 @default.
• W2127289995 hasBestOaLocation W21272899951 @default.
• W2127289995 hasConcept C126322002 @default.
• W2127289995 hasConcept C150008808 @default.
• W2127289995 hasConcept C185592680 @default.
• W2127289995 hasConcept C190283241 @default.
• W2127289995 hasConcept C2776297358 @default.
• W2127289995 hasConcept C2776694085 @default.
• W2127289995 hasConcept C2777292972 @default.
• W2127289995 hasConcept C2778119113 @default.
• W2127289995 hasConcept C2778239845 @default.
• W2127289995 hasConcept C2780350996 @default.
• W2127289995 hasConcept C2781190966 @default.
• W2127289995 hasConcept C2781451048 @default.
• W2127289995 hasConcept C502942594 @default.

• next